Wegovy

Wegovy (semaglutide) is a prescription medication used to treat Chronic weight management, cardiovascular risk reduction. A higher-dose semaglutide injection approved specifically for chronic weight management in adults and adolescents with obesity.

Activates GLP-1 receptors in the brain to reduce appetite and food intake, leading to significant, sustained weight loss.

Commonly reported side effects of Wegovy include Nausea, Diarrhea, Vomiting, Constipation, Gallbladder problems, and Thyroid tumor risk. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Wegovy carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Wegovy is semaglutide, which belongs to a class of medicines known as GLP-1 Receptor Agonist.

Wegovy is manufactured by Novo Nordisk. It was first approved in 2021.

You may be able to lower the cost of Wegovy by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.